| Literature DB >> 22480568 |
Antonia Isabel Martos1, Estrella Martín-Mazuelos, Ana Romero, Carmen Serrano, Trinidad González, Carmen Almeida, Beatriz Puche, Emilia Cantón, Javier Pemán, Ana Espinel-Ingroff.
Abstract
We tested the susceptibility of caspofungin, micafungin, and anidulafungin against Aspergillus spp. isolates by the new Clinical and Laboratory Standards Institute M51-A disk diffusion (DD) and the broth microdilution methods. A total of 65 clinical isolates of Aspergillus spp. were evaluated. The DD assay was performed on nonsupplemented Müeller-Hinton agar using caspofungin 2-μg, micafungin 1-μg, and anidulafungin 2-μg disks. Echinocandin minimal effective concentrations (MECs) and inhibition zones (IZs) were read after 24 to 48 (A. terreus) h at 35 °C. Caspofungin MECs for all Aspergillus spp. strains tested were ≤ 0.25 μg/mL; IZs were ≥ 15 mm for most species except for A. terreus (11-22 mm). Both micafungin and anidulafungin MECs were ≤ 0.015 μg/mL, but micafungin IZs were ≥ 14 mm while anidulafungin IZs were ≥ 22 mm. As for caspofungin, the DD method could be a useful method for susceptibility testing of micafungin and anidulafungin against Aspergillus spp. CrownEntities:
Mesh:
Substances:
Year: 2012 PMID: 22480568 DOI: 10.1016/j.diagmicrobio.2012.01.006
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803